Ebamed
5 known investors
Find your way into Ebamed
Sign up to see every warm intro you have to Ebamed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ebamed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.
Founders & leadership
GL

Giovanni LeoCo-Founder
DP

Douglas PackerCo-Founder & Key Advisor
UA

Ugo AmaldiCo-Founder & Key Advisor
AG

Adriano GaronnaChief Technology OfficerAdriano Garonna is Chief Technology Officer of EBAMed, which develops non-invasive cardiac ablation technology using particle and proton beam therapy to treat cardiac arrhythmias.
OC

Olivier CoquozHead of R&D
MG
Marcin GołębickiChief Executive Officer
Investors · 5
Frequently asked questions
- What does Ebamed do?
- EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.
- Who founded Ebamed?
- Ebamed was founded by Giovanni Leo, Douglas Packer, Ugo Amaldi.
- Who are Ebamed's investors?
- Ebamed's investors include CDP Venture Capital, Elysia Capital, LIFTT, OCCIDENT, Panakes Partners.




